Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 4;25(7):4015.
doi: 10.3390/ijms25074015.

Special Issue "Development and Synthesis of Biologically Active Compounds"

Galina A Gazieva  1 , Konstantin Chegaev  2
Affiliations
Editorial

Special Issue "Development and Synthesis of Biologically Active Compounds"

Galina A Gazieva et al. Int J Mol Sci. .

Abstract

The intention of this Special Issue is to focus on new achievements in the design, preparation, and in vitro and in vivo biological evaluation of bioactive molecules that can result in the development of natural or artificial potent compounds looking for promising pharmaceuticals and agrochemicals [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Chhikara B.S., Parang K. Global Cancer Statistics 2022: The trends projection analysis. Chem. Biol. Lett. 2023;10:451
    1. Sodano F., Rolando B., Lazzarato L., Costamagna C., Failla M., Riganti C., Chegaev K. Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells. Int. J. Mol. Sci. 2023;24:11258. doi: 10.3390/ijms241411258. - DOI - PMC - PubMed
    1. Chegaev K., Riganti C., Lazzarato L., Rolando B., Guglielmo S., Campia I., Fruttero R., Bosia A., Gasco A. Nitric oxide donor doxorubicins accumulate into doxorubicin-resistant human colon cancer cells inducing cytotoxicity. ACS Med. Chem. Lett. 2011;2:494–497. doi: 10.1021/ml100302t. - DOI - PMC - PubMed
    1. Riganti C., Miraglia E., Viarisio D., Costamagna C., Pescarmona G., Ghigo D., Bosia A. Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux. Cancer Res. 2005;65:516–525. doi: 10.1158/0008-5472.516.65.2. - DOI - PubMed
    1. Masetto F., Chegaev K., Gazzano E., Mullappilly N., Rolando B., Arpicco S., Fruttero R., Riganti C., Donadelli M. MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells. Biochim. Biophys. Acta Mol. Cell Res. 2020;1867:118824. doi: 10.1016/j.bbamcr.2020.118824. - DOI - PubMed

Publication types

LinkOut - more resources